Viewing

News

Physicians struggling under the strains of the pandemic often think they cannot seek professional counseling, as burnout is at an all-time high and more than 50% of ophthalmologists saw their incomes drop by more than 50%.

Humoral immunity against SARS-CoV-2 may not last long in individuals who had mild infections, and the loss of antibodies may actually be quicker than reported previously for the virus, according to investigators from the David Geffen School of Medicine, University of California, Los Angeles.

COVID-19 pandemic driving jump in Medicaid enrollment

According to an analysis of Medicaid enrollment data during the coronavirus disease 2019 (COVID-19) pandemic, there has been an increase in enrollment during the crisis. This shift is likely to have a ripple effect throughout the healthcare landscape, including ophthalmology.

Divya Srikumaran, MD, assistant professor of ophthalmology at the Wilmer Eye Institute (Johns Hopkins University)

Divya Srikumaran, MD, assistant professor of Ophthalmology at the Wilmer Eye Institute (Johns Hopkins University), discusses the results of a study published in the American Journalism of Ophthalmology regarding the growth and shift of the physician assistant profession into specialty care as well as the more valuable role PAs are taking in providing healthcare.

Wearing a face mask can help slow the spread of COVID-19, and may also lead to a spike in cases of dry eye. The Centre for Ocular Research and Education at the University of Waterloo, Ontario, Canada, is advising eye care professionals on how to recognize and mitigate mask-associated dry eye.

An ophthalmologist faces down COVID-19

A New York City physician describes how he coped with the disease in the early days of its US appearance as well as the silver lining in his diagnosis: a reinforcement of the doctor-patient relationship.

Investigators with the Texas Tech University Health Sciences Center Department of Ophthalmology and Visual Sciences have filed a US patent for a novel peptide that uses selenium as a catalyst to target vulnerable areas of coronaviruses, including COVID-19.